Point72 Middle East FZE’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,330
| Closed | -$653K | – | 1033 |
|
|
2023
Q4 | $653K | Buy |
74,330
+72,245
| +3,465% | +$635K | 0.02% | 354 |
|
|
2023
Q3 | $23.9K | Sell |
2,085
-31,655
| -94% | -$363K | ﹤0.01% | 786 |
|
|
2023
Q2 | $854K | Buy |
+33,740
| New | +$854K | 0.02% | 325 |
|
|
2023
Q1 | – | Sell |
-8,048
| Closed | -$149K | – | 1739 |
|
|
2022
Q4 | $149K | Buy |
+8,048
| New | +$149K | 0.01% | 649 |
|